These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 6750728
1. Urinary and systemic metabolites of prostacyclin in the perfused rabbit kidney. Rosenkranz B, Hofbauer K, Fischer C, Frölich JC. Ren Physiol; 1982; 5(4):186-91. PubMed ID: 6750728 [Abstract] [Full Text] [Related]
2. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. Rosenkranz B, Fischer C, Weimer KE, Frölich JC. J Biol Chem; 1980 Nov 10; 255(21):10194-8. PubMed ID: 7000774 [Abstract] [Full Text] [Related]
3. Prostacyclin metabolites in human plasma. Rosenkranz B, Fischer C, Frölich JC. Clin Pharmacol Ther; 1981 Mar 10; 29(3):420-4. PubMed ID: 7009022 [Abstract] [Full Text] [Related]
4. Metabolism of prostacyclin in the rabbit kidney. Wong PY, McGiff JC, Cagen L, Malik KU, Sun FF. J Biol Chem; 1979 Jan 10; 254(1):12-4. PubMed ID: 363716 [Abstract] [Full Text] [Related]
5. Identification of the major metabolite of prostacyclin and 6-ketoprostaglandin F1 alpha in man. Rosenkranz B, Fischer C, Reimann I, Weimer KE, Beck G, FRölich JC. Biochim Biophys Acta; 1980 Aug 11; 619(2):207-13. PubMed ID: 6996737 [Abstract] [Full Text] [Related]
6. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C, Rivoltella L, Martelli L, Valzacchi S, Fanelli R. Biochim Biophys Acta; 1992 Feb 03; 1133(3):247-54. PubMed ID: 1737057 [Abstract] [Full Text] [Related]
7. Epoxidation of prostacyclin in the rabbit kidney. Wong PY, Malik KU, Taylor BM, Schneider WP, McGiff JC, Sun FF. J Biol Chem; 1985 Aug 05; 260(16):9150-3. PubMed ID: 3894353 [Abstract] [Full Text] [Related]
8. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. Rosenkranz B, Fischer C, Reimann I, Weimer KE, Beck G, Frölich JC. Artery; 1980 Aug 05; 8(1):18-22. PubMed ID: 7000039 [Abstract] [Full Text] [Related]
9. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. Balazy M, Brass EP, Gerber JG, Nies AS. Prostaglandins; 1988 Oct 05; 36(4):421-30. PubMed ID: 3070630 [Abstract] [Full Text] [Related]
10. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry. Chiabrando C, Pinciroli V, Campoleoni A, Benigni A, Piccinelli A, Fanelli R. J Chromatogr; 1989 Oct 27; 495():1-11. PubMed ID: 2613794 [Abstract] [Full Text] [Related]
11. Identification of 6-keto-prostaglandin E1 obtained from isolated perfused kidney of the rabbit. Pieroni JP, Dray F, Pace-Asciak CR, McGiff JC. J Pharmacol Exp Ther; 1988 Oct 27; 247(1):63-8. PubMed ID: 3139870 [Abstract] [Full Text] [Related]
12. Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. Daniel VC, Minton TA, Brown NJ, Nadeau JH, Morrow JD. J Chromatogr B Biomed Appl; 1994 Mar 04; 653(2):117-22. PubMed ID: 8205238 [Abstract] [Full Text] [Related]
13. Prostacyclin metabolism in adults and neonates. Urinary profiles of 6-ketoprostaglandin F1 alpha and 2,3-dinor-6-ketoprostaglandin F1 alpha studied by gas chromatography-mass spectrometry. Fischer S, Scherer B, Weber PC. Biochim Biophys Acta; 1983 Jan 07; 750(1):127-33. PubMed ID: 6337642 [Abstract] [Full Text] [Related]
14. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. Stichtenoth DO, Selve N, Tsikas D, Gutzki FM, Frölich JC. Prostaglandins; 1995 Jan 07; 50(5-6):331-40. PubMed ID: 8838242 [Abstract] [Full Text] [Related]
15. Metabolism of prostacyclin. III. Urinary metabolite profile of 6-keto PGF1 alpha in rat. Sun FF, Taylor BM, Sutter DM, Weeks JR. Prostaglandins; 1979 May 07; 17(5):753-9. PubMed ID: 386428 [Abstract] [Full Text] [Related]
16. Transformation of prostacyclin (PGI2) to a biologically active metabolite: 5(6)-oxido-PGI1 by cytochrome P450-dependent epoxygenase. Wong PY. Adv Exp Med Biol; 1990 May 07; 281():245-50. PubMed ID: 2102615 [Abstract] [Full Text] [Related]
17. Quantitative analysis of two dinor urinary metabolites of prostaglandin I2. Falardeau P, Oates JA, Brash AR. Anal Biochem; 1981 Aug 07; 115(2):359-67. PubMed ID: 7030131 [No Abstract] [Full Text] [Related]
18. PGI2 synthesis and excretion in dog kidney: evidence for renal PG compartmentalization. Boyd RM, Nasjletti A, Heerdt PM, Baer PG. Am J Physiol; 1986 Jan 07; 250(1 Pt 2):F58-65. PubMed ID: 3079968 [Abstract] [Full Text] [Related]
19. Renal prostacyclin and thromboxane in normotensive and preeclamptic pregnant women and their infants. Ylikorkala O, Pekonen F, Viinikka L. J Clin Endocrinol Metab; 1986 Dec 07; 63(6):1307-12. PubMed ID: 3536979 [Abstract] [Full Text] [Related]
20. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney. Schwertschlag U, Stahl T, Hackenthal E. Prostaglandins; 1982 Jan 07; 23(1):129-38. PubMed ID: 7038776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]